Clinical Trials Directory

Trials / Unknown

UnknownNCT05959954

Predicting Nociplastic Pain in Carpal Tunnel Syndrome Through Quantitative Sensory Testing

Quantitative Sensory Testing to Predict Progression to Nociplastic Pain in Carpal Tunnel Syndrome: A Prospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Ahram Canadian University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the predictive value of quantitative sensory testing (QST) in identifying patients with carpal tunnel syndrome (CTS) who are at risk of developing nociplastic pain.

Detailed description

The study will recruit 120 adults diagnosed with CTS and conduct baseline QST measures. The progression to nociplastic pain will be assessed over a one-year follow-up period to determine the predictive value of QST measures.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTQuantitative Sensory Testing (QST)Quantitative Sensory Testing (QST) is a non-invasive diagnostic method used to assess sensory dysfunction. The test evaluates individual thresholds and pain responses to different types of mechanical, thermal, and electrical stimuli. For this study, QST will be used to gather baseline sensory data for patients with carpal tunnel syndrome. This information will then be used to predict the progression to nociplastic pain over a one-year follow-up period.

Timeline

Start date
2023-07-21
Primary completion
2024-07-21
Completion
2024-11-30
First posted
2023-07-25
Last updated
2023-07-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05959954. Inclusion in this directory is not an endorsement.

Predicting Nociplastic Pain in Carpal Tunnel Syndrome Through Quantitative Sensory Testing (NCT05959954) · Clinical Trials Directory